Cat |
RT‐qPCR (Neutralization test) |
1 |
1 |
‐ |
Belgium |
March, 2020 |
Garigliany et al., 2020
|
|
RT‐qPCR (Viral sequencing) |
1 |
1 |
‐ |
Brazil |
Not reported |
Carlos et al., 2021
|
|
RT‐qPCR (ELISA test, Viral sequencing and Viral isolation) |
17 |
3 |
17.65 |
Chile |
May and September, 2020 |
Neira et al., 2020
|
|
RT‐qPCR (Viral sequencing and Neutralization test) |
50 |
6 |
12.00 |
China |
February–August, 2020 |
Barrs et al., 2020
|
|
ELISA |
102 |
15 |
14.71 |
China |
January–March, 2020 |
Zhang et al., 2020
|
|
Neutralization test |
102 |
11 |
10.78 |
China |
January–March, 2020 |
Zhang et al., 2020
|
|
Neutralization test |
131 |
1 |
0.76 |
Croatia |
February–June, 2020 |
Stevanovic et al., 2020
|
|
Luciferase Immunoprecipitation Systems (LIPS) |
9 |
0 |
0.00 |
France |
March, 2020 |
Temmam et al., 2020
|
|
RT‐qPCR (Viral sequencing) |
22 |
1 |
4.55 |
France |
April, 2020 |
Sailleau et al., 2020
|
|
ELISA (Indirect immunofluorescence test (iIFT) and Neutralization test) |
920 |
6 |
0.65 |
Germany |
April–September, 2020 |
Michelitsch et al., 2020
|
|
RT‐qPCR |
314 |
0 |
0.00 |
Italy |
March and May, 2020 |
Patterson et al., 2020
|
|
Neutralization test |
191 |
11 |
5.76 |
Italy |
March and May, 2020 |
Patterson et al., 2020
|
|
RT‐qPCR (Sequencing) |
1 |
1 |
‐ |
Italy |
None specified |
Musso et al., 2020
|
|
RT‐qPCR (ELISA, Neutralization test and Viral sequencing) |
1 |
1 |
‐ |
Spain |
March–April, 2020 |
Segalés et al., 2020
|
|
RT‐qPCR |
8 |
1 |
12.50 |
Spain |
April–May, 2020 |
Ruiz‐Arrondo et el. 2020
|
|
RT‐qPCR |
2 |
2 |
‐ |
US |
March–April, 2020 |
Newman et al., 2020
|
|
RT‐qPCR (Viral isolation, Viral sequencing, and Neutralization test) |
17 |
3 |
17.65 |
US |
June–July, 2020 |
Hamer et al., 2020
|
|
ELISA/Neutralization test |
10 |
|
0.00 |
US |
None specified |
Kim et al., 2020
|
Species |
Detection method |
Analysed animals |
Positive animals |
Prevalence |
Country |
Sample period |
Reference |
Dog |
RT‐qPCR (ELISA test) |
10 |
0 |
0.00 |
Chile |
May and September, 2020 |
Neira et al., 2020
|
|
RT‐qPCR (ELISA, Neutralization test, Viral sequencing, Viral isolation) |
15 |
2 |
13.33 |
China |
February–March, 2020 |
Sit et al., 2020
|
|
Neutralization test |
654 |
2 |
0.31 |
Croatia |
February–June, 2020 |
Stevanovic et al., 2020
|
|
ELISA |
172 |
13 |
7.56 |
Croatia |
February–June, 2020 |
Stevanovic et al., 2020
|
|
Luciferase Immunoprecipitation Systems (LIPS) |
12 |
0 |
0.00 |
France |
March, 2020 |
Temmam et al., 2020
|
|
RT‐qPCR |
11 |
0 |
0.00 |
France |
April, 2020 |
Sailleau et al., 2020
|
|
RT‐qPCR |
180 |
0 |
0.00 |
Italy |
March and May, 2020 |
Patterson et al., 2020
|
|
Neutralization test |
451 |
15 |
3.33 |
Italy |
March and May, 2020 |
Patterson et al., 2020
|
|
RT‐qPCR |
12 |
0 |
0.00 |
Spain |
April–May, 2020 |
Ruiz‐Arrondo et al., 2020
|
|
RT‐qPCR (Viral isolation and Neutralization test) |
59 |
1 |
1.69 |
US |
June–July, 2020 |
Hamer et al., 2020
|
|
ELISA (Neutralization test) |
96 |
|
0.00 |
US |
None specified |
Kim et al., 2020
|